Showing results (1271-1280 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|August 27, 2016
Discovery of Fluoromethylketone-Based Peptidomimetics as Covalent ATG4B (Autophagin-1) InhibitorsZongxing Qiu, Bernd Kuhn, Johannes Aebi, et al.
ACS Medicinal Chemistry Letters|August 27, 2016
Mitochondrial-Targeting MET Kinase Inhibitor Kills Erlotinib-Resistant Lung Cancer CellsTianming Yang, Wai Har Ng, Huan Chen, et al.
ACS Medicinal Chemistry Letters|May 20, 2017
2-Aminopyrimidine Derivatives as New Selective Fibroblast Growth Factor Receptor 4 (FGFR4) InhibitorsCheng Mo, Zhang Zhang, Christopher P Guise, et al.
ACS Medicinal Chemistry Letters|May 20, 2017
Discovery of GSK2193874: An Orally Active, Potent, and Selective Blocker of Transient Receptor Potential Vanilloid 4Mui Cheung, Weike Bao, David J Behm, et al.
ACS Medicinal Chemistry Letters|May 20, 2017
Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of AsthmaDavid A Sandham, Lucy Barker, Lyndon Brown, et al.
ACS Medicinal Chemistry Letters|June 20, 2017
Where Are Drugs Invented, and Why Does It Matter?Yali Friedman
ACS Medicinal Chemistry Letters|June 20, 2017
19F-NMR-Based Dual-Site Reporter Assay for the Discovery and Distinction of Catalytic and Allosteric Kinase InhibitorsLukasz Skora, Wolfgang Jahnke
ACS Medicinal Chemistry Letters|June 20, 2017
Discovery of a Series of Indazole TRPA1 AntagonistsDavid C Pryde, Brian E Marron, Christopher W West, et al.
ACS Medicinal Chemistry Letters|June 20, 2017
Saccharin Aza Bioisosteres-Synthesis and Preclinical Property ComparisonsYantao Chen, Carl-Johan Aurell, Anna Pettersen, et al.
ACS Medicinal Chemistry Letters|September 24, 2016
Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical CandidateCatherine A Evans, Tao Liu, André Lescarbeau, et al.
Pageof 438